Further studies demonstrated that increased OS leads to telomere attrition in AATD patients and an association between telomere length and AAT phenotypes, suggesting that telomere length could be a promising biomarker for AATD disease progression [98]. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.